News|Articles|September 2, 2026

Eyes on August 2026: MIGS momentum, myopia research, and AI's reality check

Cataract safety, Glaucoma drugs and MIGS, plus Artificial Intelligence debates and retina breakthroughs—key FDA moves and trial updates in ophthalmology.

Retina specialists weighed in on the FDA's approval of bevacizumab-vikg (Lytenava) for wet age-related macular degeneration, reacting to the arrival of a lower-cost, ophthalmic-specific bevacizumab option and discussing what it could mean for treatment paradigms and off-label compounding practices going forward.

Related to this article

October 11th, 2026

AAO 2026: Are topical antibiotics necessary after intracameral prophylaxis in cataract surgery: is enough enough?

A cataract expert discussed if postoperative topical antibiotics add protection after intracameral prophylaxis.

October 11th, 2026

Clobetasol cuts post-cataract inflammation and pain in phase 3 trial

Twice-daily clobetasol 0.05% cleared cells in 26.5% vs 8.6% of patients and pain in 75.1% vs 32.4% after cataract surgery, with no added endothelial cell loss.

October 14th, 2026

AAO 2026: How to become an ocular pain detective in dry eye

Anat Galor, MD, MSPH, explains how to tell whether dry eye pain stems from the nerves or the tear film and how to target it.

October 14th, 2026

How ophthalmology researchers are applying RWD to power new insights

Discover how IRIS Registry real-world data turns EHR notes and images into evidence that speeds ophthalmology trials, recruitment, safety studies, and post-approval insights.

October 13th, 2026

AAO 2026: Planning cataract surgery in patients with uveitis

Anjum F. Koreishi, MD, explains why inflammation control and planning are key to cataract surgery for patients with uveitis.

$AAO 2026: A surf and turf approach to refractive IOL counseling$

October 12th, 2026

AAO 2026: A surf and turf approach to refractive IOL counseling

David F. Chang, MD, explained how offering complementary refractive IOLs reduces patient anxiety and indecision.

October 12th, 2026

Raising the bar on patient satisfaction: Rethinking the premium IOL conversation

A successful premium outcome depends not only on the lens, but also on how well the patient understands what to expect before surgery.

October 11th, 2026

Glaucoma surgery trends: early phaco gains in PACG as trab use falls

Initial phaco for angle-closure glaucoma climbed to 48.4% in adults 50 and older, while surveys and IRIS data show shifting trabeculectomy and JOAG surgical patterns.